The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
SAGE THERAPEUTICS, INC. | COM | 78667J108 | 6,018 | 37,362 | SH | DFND | 1,2,3 | 37,362 | 0 | 0 | |
JOUNCE THERAPEUTICS, INC. | COM | 481116101 | 228,648 | 10,230,349 | SH | DFND | 1,2,3 | 10,230,349 | 0 | 0 | |
MYOKARDIA, INC. | COM | 62857M105 | 43,193 | 885,104 | SH | DFND | 1,2,3 | 885,104 | 0 | 0 | |
BLUEPRINT MEDICINES CORPORATION | COM | 09627Y109 | 225,009 | 2,453,753 | SH | DFND | 1,2,3 | 2,453,753 | 0 | 0 | |
ALLENA PHARMACEUTICALS, INC. | COM | 018119107 | 30,756 | 2,790,964 | SH | DFND | 1,2,3 | 2,790,964 | 0 | 0 |